Psoriasis in routine clinical care: Complete skin clearance rates with guselkumab increase through week 52-Results from the real-life PERSIST study

Hoffmann M, Sticherling M, Korge B, Mortazawi D, Personke Y, Gomez M, Wegner S, Gerdes S (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Journal of the American Academy of Dermatology Elsevier

Publisher: MOSBY-ELSEVIER

City/Town: NEW YORK

Pages Range: AB177-AB177

Conference Proceedings Title: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

DOI: 10.1016/j.jaad.2021.06.721

Authors with CRIS profile

Michael Sticherling Professur für Dermatologie

Involved external institutions

Janssen-Cilag GmbH DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE)

How to cite

APA:

Hoffmann, M., Sticherling, M., Korge, B., Mortazawi, D., Personke, Y., Gomez, M.,... Gerdes, S. (2021). Psoriasis in routine clinical care: Complete skin clearance rates with guselkumab increase through week 52-Results from the real-life PERSIST study. In JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (pp. AB177-AB177). NEW YORK: MOSBY-ELSEVIER.

MLA:

Hoffmann, Matthias, et al. "Psoriasis in routine clinical care: Complete skin clearance rates with guselkumab increase through week 52-Results from the real-life PERSIST study." Proceedings of the JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY NEW YORK: MOSBY-ELSEVIER, 2021. AB177-AB177.

BibTeX: Download